The natural history of venous thromboembolism (VTE), its impact on outcome and the
rationale for prophylaxis are well established for hospitalised, acutely ill medical patients [1 …

A short-cut review was carried out to establish whether ambulatory patients immobilized in a
below knee plaster of paris cast and administered with a prophylactic dose anticoagulation …

Pulmonary embolism is the third most common cause of death from cardiovascular disease
after heart attack and stroke. Sequelae occurring after venous thromboembolism include …

Introduction: Venous thromboembolism (VTE) includes pulmonary embolism (PE), deep vein
thrombosis (DVT) in lower limbs, and thrombosis in rare locations. VTE is a common …

Each year in Australia, about 1 in 1000 people develop a first episode of venous
thromboembolism (VTE), which approximates to about 20 000 cases. More than half of these …

Venous thromboembolism (VTE) is a major cause of morbidity and mortality in both hospital
and community settings causing an estimated 60 000 deaths a year in the UK. Within this …

The majority of hospitalised patients are at risk of venous thrombosis and one in ten hospital
deaths are due to pulmonary embolism. A report from the House of Commons Health …

A short-cut review was carried out to establish whether ambulatory patients immobilized in
an above knee plaster of paris cast and administered with a prophylactic dose …

We are writing regarding our experience of attempting to calculate the costs and benefits of
implementing the recommendation by the National Institute for Health and Care Excellence …

The recent publication of the GAPS trial has led to significant uncertainty and resultant
debate about the role of mechanical methods in the prevention of venous thromboembolism …